Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease
12 April 2024 (08:30 - 14:00)
Organised by: 
About the speaker
University Medical Centre of Mannheim, Mannheim (Germany)
1 More presentation in this session
Miss N. Hukerikar (London, GB)
Access the full session
The Event
Frontiers in CardioVascular Biomedicine 2024
12 April - 14 April 2024
